1. Assessing the value of moderate‐to‐severe atopic dermatitis treatment using multi‐criteria decision analysis (MCDA).
- Author
-
Pereyra‐Rodríguez, J. J., Poveda, J. L., Rivero, A., Serra‐Baldrich, E., Silvestre, J. F., Armario‐Hita, J. C., Calleja, M. Á., Carrascosa, J. M., Flórez, Á., Herranz, P., Comellas, M., and Ortiz de Frutos, F. J.
- Subjects
MULTIPLE criteria decision making ,DECISION making ,ATOPIC dermatitis ,REPORT writing ,QUALITY of life - Abstract
This article discusses a study on the assessment of the value of treatment for moderate-to-severe atopic dermatitis (AD) using multi-criteria decision analysis (MCDA). The study aims to determine the most important health outcomes for decision-making from different perspectives. The results show that the value of a new AD treatment is primarily determined by its impact on improving patients' quality of life, controlling the disease, and reducing itching. However, there are differences in how AD patients and experts assess value, emphasizing the importance of considering the patient's opinion. The study acknowledges the limitations of the MCDA methodology and proposes a comprehensive set of criteria for evaluating AD treatments. The report was written by multiple authors and further exploration of the document is necessary to understand the specific topics and perspectives discussed. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF